Chennai, Tamil Nadu, India:TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a leader in Life Sciences (LS) and Supply Chain Management (SCM) domains, today announced its first implementation of the mobile patient reported outcomes tool ‘PaDiSys’ for a biopharmaceutical company focused on the development of small molecule drugs for major unmet medical needs that treat male and female reproductive disorders. TAKE is the exclusive reseller worldwide of PaDiSys through a strategic partnership with NowPos, a company that specializes in developing mobile-based solutions for Life Sciences.
The PaDiSys(Patient Diary System) solution helps sponsors to improve patients’ treatment adherence and compliance towards the protocol and patient reported outcomes. PaDiSys allows sponsors to walk away from a paper based approach to filling out questionnaires and assessments during clinical trials, thereby enabling the clinical staff to closely monitor patient compliance and safety. Clinicians and Site staff are equipped with easy-to-use analytical dashboards that monitor patient data in real time, and can intervene when necessary to ensure compliance. With quick deployment, implementation and simple use for both subjects and clinicians, there is a much higher adherence to a study regimen, thus improving trial compliance.
Ram Yeleswarapu, President & CEO, said “TAKE has been providing solutions and services to life sciences customers for 12 years, and safety is one of our core areas of expertise. In partnership with NowPos, we can provide biopharmaceutical companies with cutting edge mobile technology and quality, while reducing costs and accelerating trial execution.”
Vikram Marla, CEO, NowPos M-Solutions, said “The PaDiSys platform caters to clinical research studies across therapeutic areas. Flexible configuration allows the product to be used in different types of research, ranging from drug efficacy, behavioral, observational, adherence, quality of life, or lifestyle based studies in various therapeutic areas. He further added, “PaDiSys was developed from the ground up by embracing key aspects of mobile technology and the need for a low cost turnkey solution. Our strategic partnership with TAKE, along with their vast network of clients, is helping us reach out to the core Pharmaceutical community needing to improve their PRO and study compliance by many folds.”
NowPos specializes in the development of products and custom applications using mobile technology in the field of life sciences. PaDiSys is a patient diary system designed to capture patient reported outcome (PRO) and help patients manage their treatment adherence, thereby enabling clinicians to perform timely intervention during regulated clinical trials and outcomes research studies. NowPos has its global headquarters in Hyderabad, India; Its US Headquarters is located in Oak Park, CA. For more information, please visit www.NowPos.com.
About TAKE SOLUTIONS:
TAKE Solutions, Ltd. [BSE: 532890 | NSE: TAKE] is a leading global business technology company with domain expertise in Life Sciences (LS) and Supply Chain Management (SCM). TAKE provides cost-effective and comprehensive solutions for enterprises across diverse sectors including pharmaceuticals, high technology, consumer packaged goods, oil/gas, and automotive. TAKE’s SCM product suite includes distinct technology with embedded IP that spans enterprise mobility, trading partner collaboration, and material tracking. In the LS domain, TAKE offers IP-based software and extensive knowledge-based solutions to enable efficient clinical, regulatory, safety and commercialization processes.
TAKE has been recognized as a leader by IDC’s MarketScape Worldwide Life Sciences R&D IT Outsourcing for 2011.TAKE’s global headquarters is in Chennai, India; its U.S. headquarters is located in Princeton, New Jersey. TAKE has a proven track record as a trusted partner in delivering world-class solutions to more than 400 customers worldwide. For more information, please visit www.takesolutions.com
Annapoorna K, TAKE Solutions, +91 (44) 45909185